Pfizer Zoloft Ad Cited By FDA For Omitting Suicide Risk
This article was originally published in The Pink Sheet Daily
Executive Summary
FDA's ad review division objects to an October print ad for the antidepressant that failed to mention the risk of suicidality and clinical worsening. The ad's brief summary referenced information from outdated labeling, the agency says.